scholarly journals Clinical practice guidelines for the management of invasive Candida infections in adults in the Middle East region: Expert panel recommendations

2014 ◽  
Vol 7 (1) ◽  
pp. 6-19 ◽  
Author(s):  
Adel F. Alothman ◽  
Tariq Al-Musawi ◽  
Hail M. Al-Abdely ◽  
Jameela Al Salman ◽  
Muna Almaslamani ◽  
...  
Keyword(s):  
Clinical Practice ◽  
Middle East ◽  
Clinical Practice Guidelines ◽  
Practice Guidelines ◽  
Expert Panel ◽  
East Region ◽  
Candida Infections ◽  
Middle East Region

scholarly journals Clinical practice guidelines for the treatment of invasive Aspergillus infections in adults in the Middle East region: Expert panel recommendations

2014 ◽  
Vol 7 (1) ◽  
pp. 20-31 ◽  
Author(s):  
Hail M. Al-Abdely ◽  
Adel F. Alothman ◽  
Jameela Al Salman ◽  
Tariq Al-Musawi ◽  
Muna Almaslamani ◽  
...  
Keyword(s):  
Clinical Practice ◽  
Middle East ◽  
Clinical Practice Guidelines ◽  
Practice Guidelines ◽  
Expert Panel ◽  
East Region ◽  
Middle East Region

scholarly journals Management of Hepatocellular Carcinoma in Japan: JSH Consensus Statements and Recommendations 2021 Update

Liver Cancer ◽  
2021 ◽  
pp. 1-43
Author(s):  
Masatoshi Kudo ◽  
Yusuke Kawamura ◽  
Kiyoshi Hasegawa ◽  
Ryosuke Tateishi ◽  
Kazuya Kariyama ◽  
...  
Keyword(s):  
Hepatocellular Carcinoma ◽  
Clinical Practice ◽  
Public Relations ◽  
Clinical Practice Guidelines ◽  
Practice Guidelines ◽  
Expert Panel ◽  
Clinical Practices ◽  
Fourth Edition ◽  
Level Of Evidence ◽  
Consensus Statements

The Clinical Practice Manual for Hepatocellular Carcinoma was published based on evidence confirmed by the Evidence-based Clinical Practice Guidelines for Hepatocellular Carcinoma along with consensus opinion among a Japan Society of Hepatology (JSH) expert panel on hepatocellular carcinoma (HCC). Since the JSH Clinical Practice Guidelines are based on original articles with extremely high levels of evidence, expert opinions on HCC management in clinical practice or consensus on newly developed treatments are not included. However, the practice manual incorporates the literature based on clinical data, expert opinion, and real-world clinical practice currently conducted in Japan to facilitate its use by clinicians. Alongside each revision of the JSH Guidelines, we issued an update to the manual, with the first edition of the manual published in 2007, the second edition in 2010, the third edition in 2015, and the fourth edition in 2020, which includes the 2017 edition of the JSH Guideline. This article is an excerpt from the fourth edition of the HCC Clinical Practice Manual focusing on pathology, diagnosis, and treatment of HCC. It is designed as a practical manual different from the latest version of the JSH Clinical Practice Guidelines. This practice manual was written by an expert panel from the JSH, with emphasis on the consensus statements and recommendations for the management of HCC proposed by the JSH expert panel. In this article, we included newly developed clinical practices that are relatively common among Japanese experts in this field, although all of their statements are not associated with a high level of evidence, but these practices are likely to be incorporated into guidelines in the future. To write this article, coauthors from different institutions drafted the content and then critically reviewed each other’s work. The revised content was then critically reviewed by the Board of Directors and the Planning and Public Relations Committee of JSH before publication to confirm the consensus statements and recommendations. The consensus statements and recommendations presented in this report represent measures actually being conducted at the highest-level HCC treatment centers in Japan. We hope this article provides insight into the actual situation of HCC practice in Japan, thereby affecting the global practice pattern in the management of HCC.

Clinical Practice Guidelines for the Management of Sporotrichosis: 2007 Update by the Infectious Diseases Society of America

2007 ◽  
Vol 45 (10) ◽  
pp. 1255-1265 ◽  
Author(s):  
Carol A. Kauffman ◽  
Beatriz Bustamante ◽  
Stanley W. Chapman ◽  
Peter G. Pappas
Keyword(s):  
Clinical Practice ◽  
Infectious Diseases ◽  
Pregnant Women ◽  
Clinical Practice Guidelines ◽  
Practice Guidelines ◽  
Expert Panel ◽  
Evidence Based ◽  
Family Practitioners

Abstract Guidelines for the management of patients with sporotrichosis were prepared by an Expert Panel of the Infectious Diseases Society of America and replace the guidelines published in 2000. The guidelines are intended for use by internists, pediatricians, family practitioners, and dermatologists. They include evidence-based recommendations for the management of patients with lymphocutaneous, cutaneous, pulmonary, osteoarticular, meningeal, and disseminated sporotrichosis. Recommendations are also provided for the treatment of sporotrichosis in pregnant women and in children.

Failure Mode and Effect Analysis (FMEA) may enhance implementation of clinical practice guidelines: An experience from the Middle East

2017 ◽  
Vol 24 (1) ◽  
pp. 206-211 ◽  
Author(s):  
Amir Babiker ◽  
Yasser S. Amer ◽  
Mohamed E. Osman ◽  
Ayman Al‐Eyadhy ◽  
Solafa Fatani ◽  
...  
Keyword(s):  
Clinical Practice ◽  
Middle East ◽  
Failure Mode ◽  
Clinical Practice Guidelines ◽  
Practice Guidelines ◽  
Effect Analysis

scholarly journals Evaluation of the quality of published SCI clinical practice guidelines using the AGREE II instrument: Results from Can-SCIP expert panel

2021 ◽  
Vol 44 (sup1) ◽  
pp. S69-S78
Author(s):  
Eleni M. Patsakos ◽  
B. Catharine Craven ◽  
Ailene Kua ◽  
Christiana l. Cheng ◽  
Janice Eng ◽  
...  
Keyword(s):  
Clinical Practice ◽  
Clinical Practice Guidelines ◽  
Practice Guidelines ◽  
Expert Panel ◽  
Agree Ii ◽  
Agree Ii Instrument

scholarly journals Barriers to and Facilitators of Adherence to Clinical Practice Guidelines in the Middle East and North Africa Region: A Systematic Review

Healthcare ◽  
2020 ◽  
Vol 8 (4) ◽  
pp. 564
Author(s):  
Saja H. Almazrou ◽  
Sarah I. Alfaifi ◽  
Sumayyah H. Alfaifi ◽  
Lamees E. Hakami ◽  
Sinaa A. Al-Aqeel
Keyword(s):  
Clinical Practice ◽  
Middle East ◽  
Environmental Factors ◽  
Clinical Practice Guidelines ◽  
North Africa ◽  
Practice Guidelines ◽  
Financial Incentives ◽  
English Language ◽  
Mena Region ◽  
Related Factors

The current review aims to investigate the barriers to and facilitators of the adherence to clinical practice guidelines (CPGs) in the Middle East and North Africa (MENA) region. English language studies published between January 2010 and May 2019 were searched on PubMed, Embase, and EBSCO. The barriers were categorized as clinician-related factors, such as lack of awareness of familiarity with the CPGs, and external factors, such as patients, guidelines, and environmental factors. The search identified 295 titles, out of which 15 were included. Environmental factors, specifically lack of time, resources, incentives, availability, and costs of treatment or diagnostic tests, training, and dissemination plans were the most commonly identified barriers. The familiarity with or awareness of healthcare professionals about the guideline, guideline characteristics, lack of agreement with the guidelines and preference in clinical judgment, physician self-efficacy, and motivation were reported to a lesser extent. Few studies reported on the compliance of facilitators with the guidelines including disseminating and advertising guideline materials, education and training on the guidelines, regulatory and financial incentives, and support from institutions. The review highlights that the studies on barriers to and facilitators of compliance with CPGs in the MENA region are limited in number and quality.

Clinical practice guidelines for management of neuropathic pain: expert panel recommendations for South Africa

2013 ◽  
Vol 55 (2) ◽  
pp. 143-156
Author(s):  
S Chetty ◽  
E Baalbergen ◽  
AI Bhigjee ◽  
P Kamerman ◽  
J Ouma ◽  
...  
Keyword(s):  
South Africa ◽  
Neuropathic Pain ◽  
Clinical Practice ◽  
Clinical Practice Guidelines ◽  
Practice Guidelines ◽  
Expert Panel

scholarly journals Assessing the Quality of Clinical Practice Guidelines in the Middle East and North Africa (MENA) Region: A Systematic Review

2021 ◽  
Vol Volume 14 ◽  
pp. 297-309
Author(s):  
Saja H Almazrou ◽  
Layan A Alsubki ◽  
Norah A Alsaigh ◽  
Wadha H Aldhubaib ◽  
Sharifah M Ghazwani
Keyword(s):  
Systematic Review ◽  
Clinical Practice ◽  
Middle East ◽  
Clinical Practice Guidelines ◽  
North Africa ◽  
Practice Guidelines ◽  
Mena Region

scholarly journals Initial Management of Noncastrate Advanced, Recurrent, or Metastatic Prostate Cancer: ASCO Guideline Update

2021 ◽  
pp. JCO.20.03256
Author(s):  
Katherine S. Virgo ◽  
R. Bryan Rumble ◽  
Ronald de Wit ◽  
David S. Mendelson ◽  
Thomas J. Smith ◽  
...  
Keyword(s):  
Prostate Cancer ◽  
Clinical Practice ◽  
Clinical Practice Guidelines ◽  
Practice Guidelines ◽  
Metastatic Prostate Cancer ◽  
Expert Panel ◽  
Locally Advanced ◽  
Local Treatment ◽  
Phase Iii ◽  
Standards Of Care

PURPOSE Update all preceding ASCO guidelines on initial hormonal management of noncastrate advanced, recurrent, or metastatic prostate cancer. METHODS The Expert Panel based recommendations on a systematic literature review. Recommendations were approved by the Expert Panel and the ASCO Clinical Practice Guidelines Committee. RESULTS Four clinical practice guidelines, one clinical practice guidelines endorsement, 19 systematic reviews with or without meta-analyses, 47 phase III randomized controlled trials, nine cohort studies, and two review papers informed the guideline update. RECOMMENDATIONS Docetaxel, abiraterone, enzalutamide, or apalutamide, each when administered with androgen deprivation therapy (ADT), represent four separate standards of care for noncastrate metastatic prostate cancer. Currently, the use of any of these agents in any particular combination or series cannot be recommended. ADT plus docetaxel, abiraterone, enzalutamide, or apalutamide should be offered to men with metastatic noncastrate prostate cancer, including those who received prior therapies, but have not yet progressed. The combination of ADT plus abiraterone and prednisolone should be considered for men with noncastrate locally advanced nonmetastatic prostate cancer who have undergone radiotherapy, rather than castration monotherapy. Immediate ADT may be offered to men who initially present with noncastrate locally advanced nonmetastatic disease who have not undergone previous local treatment and are unwilling or unable to undergo radiotherapy. Intermittent ADT may be offered to men with high-risk biochemically recurrent nonmetastatic prostate cancer. Active surveillance may be offered to men with low-risk biochemically recurrent nonmetastatic prostate cancer. The panel does not support use of either micronized abiraterone acetate or the 250 mg dose of abiraterone with a low-fat breakfast in the noncastrate setting at this time. Additional information is available at www.asco.org/genitourinary-cancer-guidelines .

Sign in / Sign up

Export Citation Format

Share Document